System and method for dynamically adjusting analytical accuracy in clinical diagnostic procedures

By dynamically adjusting the analysis accuracy in clinical diagnostic analyzers, the problem of fixed analysis accuracy in the prior art is solved, and accuracy adjustment in different clinical scenarios is achieved, reducing analysis inaccuracy and testing costs.

CN118985028APending Publication Date: 2024-11-19BIO RAD LABORATORIES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380025963.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-03-09
Filing Date
2023-03-08
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

During the existing clinical diagnosis process, the analytical accuracy of the test results is fixed and cannot be adjusted dynamically, resulting in the need to use multiple separate test methods in different clinical scenarios, which increases cost and complexity, especially related to key medical decisions. Analysis of insufficient accuracy at concentration.

Method used

By evaluating multiple replicate samples in a clinical diagnostic analyzer, the analysis accuracy is calculated and the number of replicates of the test is dynamically adjusted to reduce analysis inaccuracy and automatically adjust the analysis accuracy of the test according to different analysis concentrations or clinical scenarios.

Benefits of technology

It realizes dynamic adjustment of analysis accuracy in different clinical scenarios, reduces analysis inaccuracy, reduces unnecessary test times, and improves the accuracy and efficiency of test results.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118985028A_ABST
    Figure CN118985028A_ABST
Patent Text Reader

Abstract

A system and method for dynamically adjusting analytical accuracy of a clinical diagnostic process is disclosed. The system and method employ a clinical diagnostic analyzer that evaluates the sample and determines whether the resulting value or average value is within a predetermined window or within a threshold of a predetermined value of a precision profile. If so, the analyzer automatically and dynamically determines the desired analysis accuracy and performs additional testing on the repeating sample to achieve the desired accuracy and reports the results to the user.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims the benefit of U.S. Provisional Patent Application No. 63 / 269,074, filed on March 9, 2022, the disclosure of which is incorporated herein by reference in its entirety. Background Art

[0003] The present invention relates generally to clinical diagnostic procedures, and more particularly to systems and methods for dynamically adjusting analytical accuracy in such procedures using clinical diagnostic analyzers, and systems and peer groups including such analyzers.

[0004] Clinical diagnostic laboratories rely on their processes and laboratory instrumentation, such as clinical diagnostic assays, to provide accurate results so that physicians, medical professionals, and patients can make informed decisions regarding patient health and patient care.

[0005] When performing clinical diagnostic tests (such as testing patient specimens), and when providing the results of these tests, it is important that the test results are meaningful and useful, and that these results are accurate and precise. Accuracy generally refers to the closeness of a test result to the actual or true value, while precision generally refers to consistency or the degree to which repeated test results agree with each other. The analytical accuracy of a clinical diagnostic procedure, clinical diagnostic analyzer, etc. is often evaluated based on the range or spread of the test results, and therefore, analytical accuracy is inherently related to the standard deviation of repeated or replicate measurements.

[0006] Thus, typical clinical diagnostic tests and procedures have an analytical precision inherent to the defined test method, i.e., the analytical precision of the test is fixed. If a different precision is needed or desired, a different defined test with a different analytical precision is required. Because each additional evaluation of a patient specimen incurs additional cost, different test methods are used in different clinical scenarios. For example, a less expensive screening test to determine whether someone is likely to have diabetes does not require the analytical precision of a more expensive treatment monitoring test to determine whether a patient has made incremental progress in the treatment of that condition.

[0007] Similarly, the intrinsic analytical precision of a test method may be adequate at certain analytical concentrations but inadequate at others, particularly at concentrations associated with critical medical decision limits. Thus, while useful, the current clinical diagnostic process requires multiple individual test methods, each with a desired intrinsic analytical precision. Summary of the invention

[0008] The present invention relates to a system and method for dynamically adjusting analysis accuracy in a clinical diagnostic process employing a clinical diagnostic analyzer and in a system, a group of systems, and a peer group of systems employing a clinical diagnostic analyzer.

[0009] In an exemplary embodiment, the system and method of the present invention uses one or more clinical diagnostic analyzers to test patient specimens and dynamically adjust the analytical accuracy of the test according to different analytical concentrations or according to different clinical scenarios.

[0010] In one aspect, the systems and methods of the present invention evaluate multiple replicates and report the mean value of the replicates evaluated. The analytical precision is calculated by dividing the SD (standard deviation) of the sample evaluated by the square root of the number of samples evaluated. Therefore, each additional replication of the evaluation reduces the analytical imprecision by 1n times, where n is the number of evaluations completed when the mean value is reported.

[0011] For example, if a sample is tested two (2) times, the analytical imprecision is reduced by a factor of 0.707, and the CV (coefficient of variation) of the mean will therefore be 0.707*the CV of the individual assessment. If a sample is tested three (3) times, the analytical imprecision is reduced by a factor of 0.577, and the CV of the mean will be 0.577*the CV of the individual assessment. And, if a sample is tested four (4) times, the analytical imprecision is reduced by a factor of 0.5, and the CV of the mean will be 0.5*the CV of the individual assessment, etc. Thus, analytical imprecision can be reduced by testing sufficient replicates of a patient sample.

[0012] In an exemplary embodiment, the clinical diagnostic analyzer evaluates the sample and determines whether the result value or average value is within a predetermined window or within a threshold value of a predetermined value of the accuracy profile. If so, the analyzer automatically and dynamically determines the desired analytical accuracy, and performs additional tests on repeated samples to achieve the desired accuracy, and reports the results to the user. In further embodiments, the analyzer reports the intermediate results of the analysis to the user. In other exemplary embodiments, the user selects the desired analytical accuracy for the test, and the clinical diagnostic analyzer dynamically adjusts the number of repeated tests to achieve the desired accuracy.

[0013] Reference to the remainder of the specification, including the drawings and claims, will recognize other features and advantages of the present invention. Other features and advantages of the present invention, as well as the structure and operation of various embodiments of the present invention, are described in detail below with reference to the drawings and claims. In the drawings, the same reference numerals represent the same or functionally similar elements. BRIEF DESCRIPTION OF THE DRAWINGS

[0014] The present invention will be described in more detail in the following detailed description of the invention with reference to the accompanying drawings which form a part hereof, in which:

[0015] Figure 1 Depicted is a block diagram of a clinical diagnostic analyzer system having multiple clinical diagnostic analyzers in communication with a server via a network in accordance with an exemplary embodiment of the present invention.

[0016] Figure 2 Depicted Figure 1 Block diagram of a single clinical diagnostic analyzer of the system.

[0017] Figure 3A Is Figure 2 A depiction of a first exemplary prompt screen presented by a clinical diagnostic analyzer.

[0018] Figure 3B Is Figure 2 A depiction of a second exemplary prompt screen presented by a clinical diagnostic analyzer.

[0019] Figure 3C Is Figure 2 A depiction of a third exemplary prompt screen presented by a clinical diagnostic analyzer.

[0020] Figure 4 Multiple peer-to-peer group configurations Figure 1 A block diagram of a clinical diagnostic analyzer is shown.

[0021] Figure 5 is a flow chart of an exemplary method for creating an accuracy profile for use in a clinical diagnostic process according to an exemplary embodiment of the present invention.

[0022] Figure 6 is a flow chart of an exemplary method for dynamically adjusting analysis accuracy to meet clinical requirements according to an exemplary embodiment of the present invention. DETAILED DESCRIPTION

[0023] Described herein are systems and methods for dynamically adjusting the analytical accuracy in a clinical diagnostic process in a clinical diagnostic analyzer, in a group of clinical diagnostic analyzers, in a system including a clinical diagnostic analyzer, and in a system of clinical diagnostic analyzers connected in a peer group according to exemplary embodiments of the present invention. Although the present invention will be described in detail below with reference to the depicted exemplary embodiments and alternative embodiments, it should be understood that the present invention is not limited to the specific configurations shown and described in these embodiments. On the contrary, it will be appreciated by those skilled in the art that various configurations may be implemented according to the present invention.

[0024] First Look Figure 1, a clinical diagnostic system according to an exemplary embodiment of the present invention is generally depicted by the numeral 100. The system 100 generally includes a plurality of clinical diagnostic analyzers 110a, 110b, 110c, 110n and a server 112 in communication with a database 114. The plurality of clinical diagnostic analyzers 110a, 110b, 110c, 110n communicate with a network 116 that facilitates the transmission of instructions, information, and data between each clinical diagnostic analyzer 110a, 110b, 110c, 110n and the server 112, and between each of the clinical diagnostic analyzers 110a, 110b, 110c, 110n and any other diagnostic analyzer or between any combination of clinical diagnostic analyzers and / or servers.

[0025] The network 116 may be any local area network (LAN), wide area network (WAN), ad-hoc network, or other network configuration known in the art, or a combination thereof. Figure 1 In the exemplary embodiment depicted in , the network 116 may include a LAN that allows communication between the clinical diagnostic analyzers 110a, 110b, 110c, 110n, such as in a single laboratory setting with multiple clinical diagnostic analyzers, and may also include a WAN, such as the Internet or other wide area network, that allows communication between the LAN and the server 112 and / or between the clinical diagnostic analyzers and the server.

[0026] It should be understood that Figure 1 The configurations depicted in are exemplary and non-limiting, and the invention as described herein may be embodied in a single clinical diagnostic analyzer, in a group of clinical diagnostic analyzers co-located in a single laboratory or facility, and in a geographically dispersed group of clinical diagnostic analyzers.

[0027] For example, multiple systems 100, each including one or more clinical diagnostic analyzers and a server, may be located in a single laboratory, or in multiple laboratories dispersed across a facility or around the world, all communicating via a WAN. It should also be understood that the present invention may be embodied in a single clinical diagnostic analyzer, or in a group of clinical diagnostic analyzers that communicate with each other via a LAN or WAN, without the need for one or more servers. These and other variations and embodiments will be apparent to those skilled in the art.

[0028] In an exemplary embodiment, Figure 4 As shown, multiple clinical diagnostic systems 150a, 150b, 150c, 150n (such as Figure 1150a, 150b, 150c, 150n represent a laboratory with one or more clinical diagnostic analyzers, and wherein each laboratory performs testing of patient specimens and quality control materials. Most preferably, each member 150a, 150b, 150c, 150n of the peer group 152 is a laboratory at a location geographically dispersed from the other peer group member laboratories, wherein each laboratory has a similar type of clinical diagnostic analyzer, runs similar types of tests, and uses quality control materials similar to those used by other peer members of the peer group.

[0029] Back to Figure 1 , the server 112 preferably includes a processor 118, a memory 120, and a logic and control circuit 122, all of which communicate with each other. The server 112 can be any server, server system, computer or computer system known in the art, preferably configured to transmit instructions and data between the server 112 and the network, and / or transmit instructions and data to any device connected to the network, and store data and information to the database 114 and retrieve data and information from the database 114. The processor 118 can be any microprocessor, controller or multiple such devices known in the art. The processor 118 preferably runs a server operating system, such as Linux-based, Windows-based or other server operating systems known in the art. Preferably, the processor 118 is configured to control the operation of the server 112 in conjunction with the operating system, allowing the server to communicate with the database 114 and the network 116 and / or with the device (such as clinical diagnostic analyzer 110a, 110b, 110c, 110n) connected to the network. In some embodiments, the server can control the operation of the clinical diagnostic analyzers, such as allowing operation of the analyzers during specific time periods, collecting data from the analyzers for storage in the database 114, transmitting data to the analyzers for viewing and / or analysis, collecting test data from the analyzers, and providing data, instructions, or prompts to the analyzers individually or in groups.

[0030] The memory 120 may be volatile or non-volatile memory and is used to store data and information associated with the operation of the server and data for transmission to and from the server. For example, the memory stores a server operating system for execution by the processor 118 and may also store data associated with the clinical diagnostic analyzers 110a, 110b, 110c, 110n that communicate with the server 112 via the network 116. In some embodiments, the memory 120 on the server may be used in addition to or in place of the database 114.

[0031] The database 114 is preferably used to store control information related to the operation of the server 112 and the operation and control of the clinical diagnostic analyzers 110a, 110b, 110c, 110n, and may also be used to store data related to the processing of samples by the clinical diagnostic analyzers. For example, the database may contain instructions or programs for execution by a processor on the clinical diagnostic analyzer or for execution on the server, or may store data related to the number of samples processed, the frequency of testing, the results of analyses performed on the analyzer, and data related to the samples themselves, such as tracking information, batch number, sample size, sample weight, percentage of remaining sample, etc. Preferably, the database 114 includes non-volatile memory, such as a hard disk drive, solid-state memory, and combinations thereof.

[0032] Logic and control circuitry 122 provides interface circuitry to allow the processor and memory to communicate, and provides other operating functions to the server, such as facilitating data communications to and from network 116 .

[0033] Go to Figure 2 , depicting Figure 1 Detailed view of a single clinical diagnostic analyzer 110a of the system of FIG. The clinical diagnostic analyzer 110a preferably includes a processor 124 , a memory device 126 , measurement hardware 128 , and an input panel / display 130 .

[0034] The processor 124 can be any controller, microcontroller or microprocessor known in the art, and communicates with a memory device 126, which stores instructions executed by the processor to control and communicate with the measurement hardware 128 and the input panel / display 130 to cause the clinical diagnostic analyzer to perform desired steps, such as sampling to command the measurement hardware to load a test specimen or perform a test on a loaded sample, or to instruct or prompt a user to perform a specific operation, such as changing a test sample, starting a test, or viewing collected data. The processor 124 can also execute instructions to receive data from the measurement hardware 128 and perform one or more analyses on the received data, as well as display test results or other information on the input panel / display panel 130.

[0035] The measurement hardware 128 preferably includes a sample receptacle configured to receive one or more samples or specimens into the analyzer for testing. Preferably, the measurement hardware is configured to receive samples stored in vials, and most preferably is configured to receive multiple vials and extract analytes from any desired vial for analysis. In further embodiments, the measurement hardware 128 may include an external turntable, loader, or other mechanism to facilitate loading and unloading of samples, thereby allowing samples to be loaded at the command of the analyzer.

[0036] like Figure 2 As shown, the measurement hardware is configured to be used with material samples 132a, 132b, 132c, 132d, which can be QC materials, patient test specimens, or other specimens known in the art. In one embodiment, the material samples are contained in vials, which are loaded or inserted into the clinical diagnostic analyzer 110a by the user. The samples can be loaded individually or in groups, for example in a tray loaded into the analyzer. In an alternative embodiment, an automated loading mechanism (such as a turntable or other mechanism) can be used to load the sample according to a command from the analyzer 110a. Material samples in the form of QC materials are usually provided in batches, where a unique batch number is assigned to a batch of samples that are substantially the same as from the same batch material source. The analyzer 110a preferably allows information related to the QC material to be input by the user, including statistical information, such as the average or standard deviation of the batch material. In other embodiments, information can be obtained through a network or from a server using, for example, a QR code on a sample bottle or container to uniquely identify a sample or batch.

[0037] The input panel / display 130 is in communication with the processor and is operable to present controls to facilitate operation of the analyzer, as well as present prompts and instructions to a user, and receive input commands and / or data from a user. The input panel / display 130 is preferably a touch screen having the ability to display text and graphics as well as icons, buttons, keyboards, etc., to present data to the user and receive input from a user of the analyzer. Preferably, the input panel / display 130 includes an audible alert device such as a buzzer or beeper.

[0038] See also Figure 3A , Figure 3B , Figure 3C 3D, for example, the input panel / display may present a prompt to the user to load a patient specimen and press the READY button ( Figure 3A ), start dynamic analysis of loaded patient specimens ( Figure 3B ), or view, select, store data, or select another analysis ( Figure 3C ). It should be understood that the clinical diagnostic analyzer 100a may have multiple programs and functions available, and preferably a menu or selection prompt is presented to guide the user through the operation of the analyzer and the selection of desired functions and operations.

[0039] The clinical diagnostic analyzer 110a can be any type of analyzer known in the art, such as a biochemical analyzer, a hematology analyzer, an immunological analyzer, or any other clinical diagnostic analyzer known in the art. Preferably, the analyzer 110a is configured to evaluate or test a patient specimen or sample, and automatically and dynamically adjust or control the operation of subsequent repeated evaluations to achieve the desired analytical accuracy of the test. The clinical diagnostic analyzer 110a can be configured to be used with a variety of patient specimens or samples, whether in liquid or lyophilized form, and can be configured for use in immunoassays, serum chemistry, immunology, hematology, and other fields.

[0040] Combined Figure 1 3, in a typical use of performing a test on a patient specimen, the analyzer 110a prompts the user as follows: Figure 3A Load the patient specimen as shown, and once loaded proceed as shown Figure 3B When the test is complete, the analyzer can prompt the user to store or review the data.

[0041] It should be understood that the operations of the analyzer 100a may be performed locally at the analyzer, or when the analyzer is in a Figure 1 When operating in the illustrated system 100, operations may be coordinated through a server 112. It should also be understood that any data may be stored locally on the analyzer 110a, the server 112, or the database 114, and that the data may be made available throughout the system 100 and over a network 115, such that remote servers and analyzers may also access the stored data. Similarly, the analysis may be run on the analyzer itself, on a server, or may be distributed among multiple analyzers and / or servers.

[0042] It should also be understood that data collected and / or stored on any individual clinical diagnostic analyzer in any system can be shared and transmitted to other clinical diagnostic analyzers in the same system or laboratory, can be shared and transmitted with servers and databases within the system, and can be shared and transmitted to other systems, as well as to clinical diagnostic analyzers and servers and databases within these other systems.

[0043] See also Figure 4 In an exemplary embodiment, a plurality of clinical diagnostic systems 150a, 150b, 150c, 150n (each of which is similar to Figure 1150a, 150b, 150c, 150n) communicate via a network 152 (such as the Internet or other WAN). The collection of individual systems includes a peer group 154 ​​of systems, where each system 150a, 150b, 150c, 150n represents a laboratory with one or more clinical diagnostic analyzers, and where each laboratory performs testing of patient specimens and quality control materials. Most preferably, each member 150a, 150b, 150c, 150n of the peer group 154 ​​is a laboratory at a location geographically dispersed from the other peer group member laboratories, where each laboratory has a similar type of clinical diagnostic analyzer, runs similar types of tests, and uses quality control materials similar to those used by other members of the peer group.

[0044] In embodiments of the invention described herein, analysis performed on multiple analyzers and data collected by members of a peer group may be analyzed in combination to provide an output or result based on data collected across the multiple analyzers and based on data collected by other members of the peer group.

[0045] With the described configurations of clinical diagnostic analyzers, systems employing clinical diagnostic analyzers, and peer groups of clinical diagnostic analyzers, systems and methods for dynamically adjusting analytical accuracy in a clinical diagnostic process will now be described.

[0046] First Look Figure 5 , depicts an exemplary method for creating a precision profile for a desired test method. Typically, a precision profile is created by conducting a precision study using samples of at least five (5) concentrations of the appropriate analyte for the desired test. Preferably, the five samples include one sample at each end of the desired analytical range, one sample near the medical decision point (i.e., the point at which the patient sample value would trigger a medical decision if the patient sample was above or below that point), and one sample on either side of the medical decision point. In alternative embodiments, additional samples having other concentrations may also be included in creating the precision profile.

[0047] Samples of varying concentrations are evaluated for a desired test method at block 200. Preferably, approximately at least 60 to 120 replicates of each sample are evaluated, although more or fewer evaluations may be performed depending on the desired confidence level.

[0048] At block 202, the SD of each sample is determined by performing a nonlinear regression analysis of the standard deviation (SD) of the sample over the analytical range, with the SD assigned to each concentration. It should be understood that this step can be performed in conjunction with the evaluation step of block 200, and that the SD can be determined on a running basis as the evaluation proceeds, rather than only after all evaluations have been completed.

[0049] At box 204, with the SD determined and assigned for each concentration, the profile is evaluated to determine which analytical concentration ranges may benefit from better precision, and how much additional precision is needed to adequately support clinical decisions. It should be understood that the evaluation may determine that a particular range does not require additional precision, or that one or more ranges may require testing one or more replicates and averaging with previous results to reduce the imprecision of that range to meet the desired clinical requirements.

[0050] At block 206, the accuracy profile of the test method is completed and stored in the clinical diagnostic analyzer, and / or in other networked systems or devices as previously described, for use in testing patient specimens.

[0051] For example, when creating a precise profile for a hemoglobin A1c test, it may be determined that the following adjustments should be made to the various ranges:

[0052] A1c levels of 5.7 to 6.4 – reducing imprecision by 0.707-fold,

[0053] A1c levels of 6.5 to 7.0 – reducing imprecision by a factor of 0.577,

[0054] A1c levels 7.0 to 8.0 – reduces imprecision by 0.707-fold.

[0055] These determined factors are stored in the precision profile associated with the A1c test method. Thus, when the clinical diagnostic analyzer evaluates an A1c patient sample, any results that fall within those ranges will cause the analyzer to dynamically adjust the precision of the analysis according to the associated factors, and thus evaluate an additional number of replicates of the patient sample to achieve the desired precision, i.e., reduce the imprecision of that range. As previously described, reducing the imprecision by a factor of 0.707 requires evaluating two replicates, and reducing the imprecision by a factor of 0.577 requires evaluating three replicates, and so on. It should be understood that the factors, the number of replicates to be run, and other corresponding data can be stored in the precision profile and retrieved by the clinical diagnostic analyzer for use.

[0056] Preferably, accuracy profiles for multiple test methods are created and stored on the clinical diagnostic analyzer or on the laboratory network, as previously described, for ready access by the clinical diagnostic analyzer for a particular test.

[0057] With the clinical diagnostic process and operation of the clinical diagnostic analyzer described, and the creation of an accuracy profile for a particular test method as just described, reference will now be made to Figure 6 The operation of the system and method of the present invention in dynamically adjusting the accuracy of an analysis is described.

[0058] See also Figure 6At block 250, the user selects the desired test method or analysis to be performed, such as by using Figure 3C A selection screen of a clinical diagnostic analyzer is shown. For example, a user may select to run an A1c test, an HbA2 test, or other desired test, test method, or analysis.

[0059] At box 252, using the selected test method, the clinical diagnostic analyzer accesses the accuracy profile associated with the selected test method and loads adjustment factors (or numbers of repetitions to be run) from the accuracy profile for various ranges associated with the selected test method into the clinical diagnostic analyzer.

[0060] With a test method selected and an associated precision profile loaded, at block 254 a patient specimen to be tested is loaded and analytes from the specimen are evaluated.

[0061] At block 256, the value from the evaluation is compared to the range of values ​​in the accuracy profile to determine whether the value is within a range identified in the accuracy profile as requiring additional accuracy (ie, requiring additional evaluation to be performed).

[0062] If the value at box 256 is within the identified range, then at box 258, one or more additional replicates of the patient specimen are evaluated (depending on the additional precision required and desired in the precision profile) and the average of the multiple evaluations is calculated as the result value of the evaluation. Once the evaluation of the additional replicates is completed, the process proceeds to box 260 where the results are displayed to the user and stored in the laboratory system.

[0063] If at block 256, additional precision is not required, then additional iterations are not evaluated and the process proceeds to block 260 where the results are displayed to the user.

[0064] At block 262, a user alert is generated by the clinical diagnostic analyzer if the results are outside of a predetermined window or threshold associated with the selected testing method.

[0065] Thus, the above method provides dynamically adjusted analytical accuracy for a clinical diagnostic process that is automatically performed by a clinical diagnostic analyzer without user invention or intermediate evaluation of the results.

[0066] In another example, the systems and methods of the present invention will be described in an exemplary use of a hemoglobin A2 (HbA2) test. High levels of hemoglobin A2 are used as a diagnostic test for beta thalassemia, a blood disorder that reduces hemoglobin production. If a patient is identified as having abnormally high HbA2, the patient is typically referred for definitive molecular testing. Because molecular testing is expensive, false positives for high HbA2 are undesirable.

[0067] Using the system and method of dynamically adjusting the analysis accuracy of the present invention, false positives of high HbA2 can be minimized by increasing the accuracy of samples falling in the boundary area between normal and high levels of HbA2. Therefore, when a patient sample has an initial evaluation that falls within this boundary area, the system and method as described above can instruct the clinical diagnostic analyzer to automatically evaluate one or more replicates to achieve the desired accuracy of the samples in the boundary area. Additional evaluations are performed dynamically and automatically without any user intervention, reporting higher accuracy results.

[0068] Continuing with the HbA2 example, assume that the precision profile for the HbA2 test method has the following values:

[0069]

[0070] And the HbA2 border zone is in the range of 3.1 to 3.8.

[0071] Any sample with an initial evaluation between 3.1 and 3.8 (i.e., in the borderline region) will be evaluated a second time, and the average of the two evaluations will be reported as the result. Any sample with an initial evaluation less than 3.1 or greater than 3.8 will not be evaluated again, and the initial evaluation value will be reported. For example, the following samples and initial evaluations will be evaluated and reported as follows:

[0072]

[0073]

[0074] It can be seen that samples with initial values ​​within the boundary region of 3.1 to 3.8 (i.e., samples A, C, D, E, F, and G) were dynamically and automatically evaluated a second time to reduce the imprecision by a factor of 0.707, while any samples that did not have initial values ​​within the boundary region were not dynamically and automatically evaluated a second time. Thus, the system and method of the present invention prevents unnecessary and expensive evaluations by automatically identifying only those samples that require additional evaluation.

[0075] It can be seen that the systems and methods of the present invention provide improvements over known systems and methods that are not capable of dynamically adjusting analytical accuracy during the testing of patient samples.

[0076] Although the present invention has been described and illustrated with reference to various exemplary embodiments above, it should be understood that various modifications may be made to these embodiments without departing from the scope of the present invention. Therefore, the present invention is not limited to the exemplary embodiments described and illustrated above, unless these limitations are included in the appended claims.

Claims

1. A clinical diagnostic analyzer for dynamically adjusting analytical accuracy in a clinical diagnostic test, comprising: processor; measurement hardware in communication with the processor and configured to measure a characteristic of an analyte; a memory device having executable instructions stored thereon, the executable instructions, when executed by the processor, causing the clinical diagnostic analyzer to perform operations, the operations comprising: loading and evaluating a patient specimen to determine a first value of the specimen; comparing the first value to determine whether the first value is within a first predetermined range; Upon determining that the first value is within the predetermined range, re-evaluating the patient specimen a predetermined number of times to determine a second value and reporting the second value to a user; and When it is determined that the first value is not within the first predetermined range, the first value is reported to a user.

2. The clinical diagnostic analyzer according to claim 1, wherein: The first predetermined range is loaded from an accuracy profile data file associated with the clinical diagnostic test.

3. The clinical diagnostic analyzer according to claim 2, wherein: The accuracy profile data file includes data including a first predetermined range, a second predetermined range, a predetermined number of times, a precision factor, and a combination thereof.

4. The clinical diagnostic analyzer according to claim 1, wherein: The executable instructions, when executed by the processor, further cause the clinical diagnostic analyzer to perform operations comprising: When the reported first value or the reported second value is within a second predetermined range, an alert is generated to the user.

5. The clinical diagnostic analyzer according to claim 1, wherein: Determining the second value includes calculating an average of the evaluated values.

6. A clinical diagnostic analyzer for dynamically adjusting analytical accuracy in a clinical diagnostic test, comprising: processor; measurement hardware in communication with the processor and configured to measure a characteristic of an analyte; a memory device having executable instructions stored thereon, the executable instructions, when executed by the processor, causing the clinical diagnostic analyzer to perform operations, the operations comprising: loading and evaluating a patient specimen to determine a first value of the specimen; comparing the first value to determine whether the first value is within a first predetermined range; upon determining that the first value is within the predetermined range, re-evaluating the patient sample one or more times to determine a second value for the sample; calculating an accuracy based on the first value and the second value; The accuracy is reported to the user.

7. The clinical diagnostic analyzer according to claim 5, wherein: The predetermined range is loaded from an accuracy profile data file associated with the clinical diagnostic test.

8. The clinical diagnostic analyzer according to claim 6, wherein: The accuracy profile data file includes data including predetermined ranges, precision factors, and combinations thereof.

9. The clinical diagnostic analyzer according to claim 1, wherein: The executable instructions, when executed by the processor, further cause the clinical diagnostic analyzer to perform operations comprising: When the reported accuracy exceeds a predetermined threshold, an alert is generated to the user.

10. A system for dynamically adjusting the analysis accuracy in a clinical diagnosis process, comprising: A plurality of peer group systems, wherein each peer group system comprises: A server comprising a processor, a memory and a database, wherein the server communicates with servers of other peer group systems; and a plurality of clinical diagnostic analyzers in communication with the server, wherein each of the plurality of clinical diagnostic analyzers comprises: processor; measurement hardware in communication with the processor and configured to measure a characteristic of an analyte; a memory device having executable instructions stored thereon; Wherein, the executable instructions stored on the memory device of at least one of the clinical diagnostic analyzers, when executed by a corresponding processor, cause the clinical diagnostic analyzer to perform operations, the operations comprising: loading and evaluating a patient specimen to determine a first value of the specimen; comparing the first value to determine whether the first value is within a first predetermined range; Upon determining that the first value is within the predetermined range, re-evaluating the patient specimen a predetermined number of times to determine a second value and reporting the second value to a user; and When it is determined that the first value is not within the first predetermined range, the first value is reported to a user.

11. The system according to claim 10, wherein: The first predetermined range is loaded from an accuracy profile data file associated with a clinical diagnostic test.

12. The system according to claim 11, wherein: The accuracy profile data file includes data including a first predetermined range, a second predetermined range, a predetermined number of times, a precision factor, and a combination thereof.

13. The system according to claim 10, wherein: The executable instructions, when executed by the processor, further cause the clinical diagnostic analyzer to perform operations comprising: When the reported first value or the reported second value is within a second predetermined range, an alert is generated to the user.

14. The system according to claim 10, wherein: Determining the second value includes calculating an average of the evaluated values.